Regulation of osteoclast differentiation

scientific journal article

Regulation of osteoclast differentiation is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1196/ANNALS.1346.013
P698PubMed publication ID16831910
P5875ResearchGate publication ID6953567

P2093author name stringG. David Roodman
P2860cites workRANK is essential for osteoclast and lymph node developmentQ24598872
Src kinase activity is essential for osteoclast functionQ28513236
ADAM8: a novel osteoclast stimulating factorQ28588620
Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligandQ30670375
Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorptionQ30773401
Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factorQ30961251
Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironmentQ34247917
OsteopetrosisQ34380528
Mechanisms involved in bone resorptionQ34641090
CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formationQ40666292
B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbetaQ40875461
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cellsQ40927574
Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.Q41121255
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formationQ42475736
A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive functionQ42811314
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragmentQ43755563
Bifurcation of osteoclasts and dendritic cells from common progenitorsQ43757343
Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic indexQ44032751
NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesisQ44049672
Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow culturesQ44058149
p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast functionQ44072080
M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinaseQ44591611
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.Q46375837
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiationQ57675158
P407language of work or nameEnglishQ1860
P921main subjectA disintegrin and metallopeptidase domain 8Q21495343
P304page(s)100–109
P577publication date2006-04-01
P1433published inAnnals of the New York Academy of SciencesQ2431664
P1476titleRegulation of osteoclast differentiation
P478volume1068

Reverse relations

cites work (P2860)
Q48000639A novel ex vivo culture model for inflammatory bone destruction
Q34028709Activating transcription factor 4 regulates osteoclast differentiation in mice.
Q42150169Adam8 limits the development of allergic airway inflammation in mice.
Q37318849Advances in osteoclast biology resulting from the study of osteopetrotic mutations.
Q52640427Anxa2 attenuates osteoblast growth and is associated with hip BMD and osteoporotic fracture in Chinese elderly.
Q38995801BMP-2 and titanium particles synergistically activate osteoclast formation
Q43902819Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.
Q35798517Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health
Q93029052Brief Review on Metabolic Bone Disease
Q41875199Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors
Q34460755Characterization and identification of subpopulations of mononuclear preosteoclasts induced by TNF-α in combination with TGF-β in rats
Q34077850Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils
Q37609556Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways
Q33332122Complex dynamics of osteoclast formation and death in long-term cultures
Q27653392Crystal structure of human osteoclast stimulating factor
Q42467215Differential production of macrophage inflammatory protein-1alpha, stromal-derived factor-1, and IL-6 by human cultured periodontal ligament and gingival fibroblasts challenged with lipopolysaccharide from P. gingivalis.
Q39664895Double stranded RNA-dependent protein kinase is involved in osteoclast differentiation of RAW264.7 cells in vitro
Q33784120Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro
Q36357434Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension
Q37809213Evolution of the parathyroid hormone family and skeletal formation pathways
Q38342243Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.
Q33779830Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia
Q36544723Functional osteoclastogenesis: the baseline variability in blood donor precursors is not associated with age and gender
Q33699188Gene targeting to the stroma of the prostate and bone
Q39656727Identification of Osteoclastic Factors in the Nuclear Envelope of Mature, Multinucleated Osteoclasts
Q33816415Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine.
Q34059293Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis
Q58274650In vitro cholesteatoma growth and secretion of cytokines
Q34148428Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta
Q37131738Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone
Q47730277Inhibitory effects of sesamin on human osteoclastogenesis
Q36908519Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence
Q36835789Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy
Q39922305Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice
Q34243554Krüppel-like factor 4 regulates membranous and endochondral ossification
Q33799794Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice.
Q51742926Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo.
Q36553375Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling
Q33758838Measurement by vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts on dentine slices
Q47118982Mesenchymal stem cells inhibit RANK-RANKL interactions between osteoclasts and Th17 cells via osteoprotegerin activity
Q37729189Methyl Gallate Inhibits Osteoclast Formation and Function by Suppressing Akt and Btk-PLCγ2-Ca2+ Signaling and Prevents Lipopolysaccharide-Induced Bone Loss.
Q34527129MicroRNAs involved in bone formation.
Q36745236Microstructured titanium regulates interleukin production by osteoblasts, an effect modulated by exogenous BMP-2
Q38091023Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells
Q40468875Network-based proteomic analysis for postmenopausal osteoporosis in Caucasian females.
Q34286289Novel method of murine embryonic stem cell-derived osteoclast development
Q59797072Nox2 Activity Is Required in Obesity-Mediated Alteration of Bone Remodeling
Q28274725Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity
Q34696114Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss
Q38124052Osteoporosis in older persons: current pharmacotherapy and future directions
Q39445928Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.
Q36453271Patient specific proteolytic activity of monocyte-derived macrophages and osteoclasts predicted with temporal kinase activation states during differentiation.
Q38568957Peripheral Blood Mononuclear Cells Spontaneous Osteoclastogenesis: Mechanisms Driving the Process and Clinical Relevance in Skeletal Disease
Q35579638Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans
Q35156112Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling
Q30656758Prostate cancer invasion and metastasis: insights from mining genomic data
Q37716325Quantitative proteomics and integrative network analysis identified novel genes and pathways related to osteoporosis
Q47619382Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia.
Q92377250Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway
Q41726644Role of Wnt signaling in bone remodeling and repair
Q33597248Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells
Q34983694Salivary biomarkers of periodontal disease in response to treatment
Q48049809Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.
Q26765491The Alternative Faces of Macrophage Generate Osteoclasts
Q28586398The LIM protein LIMD1 influences osteoblast differentiation and function
Q26773017The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis
Q33873578The critical role of IL-34 in osteoclastogenesis
Q37423147The molecular mechanism behind bone remodelling: a review
Q47764004The potential of mangosteen (Garcinia mangostana) peel extract, combined with demineralized freeze-dried bovine bone xenograft, to reduce ridge resorption and alveolar bone regeneration in preserving the tooth extraction socket
Q21195416Tumor metastasis to bone
Q42139802Ubiquitin E3 Ligase LNX2 is Critical for Osteoclastogenesis In Vitro by Regulating M-CSF/RANKL Signaling and Notch2.
Q36759374Understanding and targeting osteoclastic activity in prostate cancer bone metastases